FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称NATALIZUMAB
异名/同义词AN100226M
ANTEGRAN
ANTEGREN
IMMUNOGLOBULIN G4 (HUMAN-MOUSE MONOCLONAL AN100226 4-CHAIN ANTI-HUMAN INTEGRIN 4), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL AN100226 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G4 (HUMAN-MOUSE MONOCLONAL AN100226 4-CHAIN ANTI-HUMAN INTEGRIN 4), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL AN100226 LIGHT CHAIN, DIMER
NATALIZUMAB
NATALIZUMAB [EMA EPAR]
NATALIZUMAB [INN]
NATALIZUMAB [JAN]
NATALIZUMAB [MART.]
NATALIZUMAB [MI]
NATALIZUMAB [PURPLE BOOK CDER]
NATALIZUMAB [USAN]
NATALIZUMAB [VANDF]
NATALIZUMAB [WHO-DD]
NATALIZUMAB ELAN PHARMA
TYSABRI
CAS登记号189261-10-7
物质唯一标识(Unique Ingredient Identifier)3JB47N2Q2P
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System